A/H7N9

BIOLOGICAL3 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions

Avian InfluenzaInfluenza Immunisation

Phase 2

2013/2017 H7N9 Prime-Boost Interval

CompletedNCT03589807

National Institute of Allergy and Infectious Diseases (NIAID)Avian Influenza, Influenza Immunisation

Start: 2018-08-21End: 2020-06-14Updated: 2021-08-02

Safety/Efficacy Study of Seqirus A/H7N9 IIV With or Without MF59(R) Adjuvant to Prevent Avian Influenza

CompletedNCT03682120

National Institute of Allergy and Infectious Diseases (NIAID)Avian Influenza, Influenza Immunisation

Start: 2018-11-02End: 2020-04-30Updated: 2021-05-17

2017 A/H7N9 IIV Revaccination

CompletedNCT03738241

National Institute of Allergy and Infectious Diseases (NIAID)Avian Influenza, Influenza Immunisation

Start: 2018-12-18End: 2020-06-19Updated: 2021-07-30

Related Papers

Anti-neuraminidase and anti-hemagglutinin stalk responses to different influenza a(H7N9) vaccine regimens.

2025-01-042 citations

A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered With and Without AS03 Adjuvant in Healthy US Adults

Clinical Infectious Diseases2024-03-278 citations

Safety and Immunogenicity of a Delayed Heterologous Avian Influenza A(H7N9) Vaccine Boost Following Different Priming Regimens: A Randomized Clinical Trial

The Journal of Infectious Diseases2023-07-197 citations